Entity Details

Primary name P5CS_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP54886
EntryNameP5CS_HUMAN
FullNameDelta-1-pyrroline-5-carboxylate synthase
TaxID9606
Evidenceevidence at protein level
Length795
SequenceStatuscomplete
DateCreated1996-10-01
DateModified2021-06-02

Ontological Relatives

GenesALDH18A1

GO terms

Show/Hide Table
GOName
GO:0003723 RNA binding
GO:0004349 glutamate 5-kinase activity
GO:0004350 glutamate-5-semialdehyde dehydrogenase activity
GO:0005524 ATP binding
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0006536 glutamate metabolic process
GO:0006561 proline biosynthetic process
GO:0006592 ornithine biosynthetic process
GO:0009064 glutamine family amino acid metabolic process
GO:0019240 citrulline biosynthetic process
GO:0042802 identical protein binding
GO:0055129 L-proline biosynthetic process

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion inner membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000965 GPR domainDomainDomain
IPR001048 Aspartate/glutamate/uridylate kinaseDomainDomain
IPR001057 Glutamate/acetylglutamate kinaseFamilyFamily
IPR005715 Glutamate 5-kinase/delta-1-pyrroline-5-carboxylate synthaseFamilyFamily
IPR005766 Delta l-pyrroline-5-carboxylate synthetaseFamilyFamily
IPR015590 Aldehyde dehydrogenase domainDomainDomain
IPR016161 Aldehyde/histidinol dehydrogenaseFamilyHomologous superfamily
IPR016162 Aldehyde dehydrogenase, N-terminalFamilyHomologous superfamily
IPR016163 Aldehyde dehydrogenase, C-terminalFamilyHomologous superfamily
IPR019797 Glutamate 5-kinase, conserved siteSiteConserved site
IPR020593 Gamma-glutamyl phosphate reductase GPR, conserved siteSiteConserved site
IPR036393 Acetylglutamate kinase-like superfamilyFamilyHomologous superfamily
IPR041744 Bifunctional delta 1-pyrroline-5-carboxylate synthetase, glutamate-5-kinase domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
219150 OMIMCutis laxa, autosomal recessive, 3A (ARCL3A)A syndrome characterized by facial dysmorphism with a progeroid appearance, large and late-closing fontanel, cutis laxa, joint hyperlaxity, athetoid movements and hyperreflexia, pre- and postnatal growth retardation, intellectual deficit, developmental delay, and ophthalmologic abnormalities. The disease is caused by variants affecting the gene represented in this entry.
601162 OMIMSpastic paraplegia 9A, autosomal dominant (SPG9A)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG9A patients have gait difficulties, motor neuropathy, and dysarthria. Additional variable features include cerebellar signs, cataract, pes cavus, and urinary urgency. The disease is caused by variants affecting the gene represented in this entry.
616586 OMIMSpastic paraplegia 9B, autosomal recessive (SPG9B)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG9B is a complex form characterized by delayed psychomotor development, intellectual disability, and severe motor impairment. Dysmorphic facial features, tremor, and urinary incontinence are variably observed in SPG9B patients. The disease is caused by variants affecting the gene represented in this entry.
616603 OMIMCutis laxa, autosomal dominant, 3 (ADCL3)A form of cutis laxa, a connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. Additional variable clinical features are gastrointestinal diverticula, hernia, and genital prolapse. Rare manifestations are pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and emphysema. ADCL3 patients manifest thin skin with visible veins and wrinkles, cataract or corneal clouding, moderate intellectual disability, muscular hypotonia with brisk muscle reflexes, clenched fingers, and pre- and postnatal growth retardation. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00142 Glutamic acidDrugbanksmall molecule